Novel HIV Vaccine Candidate Safe, Immunogenic Next step is efficacy trial but more data needed

If that happens, it will be the second HIV vaccine candidate being tested for efficacy. A trial in South Africa, dubbed HVTN 702, is currently studying a tweaked version of the only vaccine ever to show any efficacy in preventing HIV. https://www.medpagetoday.com/MeetingCoverage/IAC/66841?xid=nl_mpt_DHE_2017-07-25&eun=g721819d0r&pos=3